Avatar
Damage4clerk

0 Following 0 Followers
1
Nopathy in the homosexual male. Am J Surg Pathol 9: 287?97. 36. Wood GS (1990) The immunohistology of lymph nodes in HIV infection: a review. Prog AIDS Pathol 2: 25?2. 37. Alter G, Teigen N, Ahern R, Streeck H, Meier A, et al. (2007) Evolution of innate and adaptive effector cell functions during acute HIV-1 infection. J Infect Dis 195: 1452?460. 38. Alter G, Teigen N, Davis BT, Addo MM, Suscovich
1
Ministered to HIV-infected young adults on highly active antiretroviral therapy (HAART).NIH-PA Author Manuscript NIH-PA Author Manuscript NIH-PA Author Manuscript2.2. Vaccine2. Materials and methodsThis was a prospective, multicenter trial carried out by the Pediatric AIDS Clinical Trials Group (PACTG) and the International Maternal, Pediatric, Adolescent, AIDS Clinical Trials (IMPAACT) network. T
1
Id onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82: 538?45. 30. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, et al. (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency viru
1
Vaccines. Recombinant poxvirus vaccines are worthy candidates given the wealth of experience using vaccinia for smallpox immunization programs in humans, and the development of recombinant techniques that enable insertion of substantial lengths of foreign DNA [1?]. More recently, attenuated strains of vaccinia have been developed (modified vaccinia Ankara; MVA) that are safer for use in young or i
1
Vaccines. Recombinant poxvirus vaccines are worthy candidates given the wealth of experience using vaccinia for smallpox immunization programs in humans, and the development of recombinant techniques that enable insertion of substantial lengths of foreign DNA [1?]. More recently, attenuated strains of vaccinia have been developed (modified vaccinia Ankara; MVA) that are safer for use in young or i
1
Atinger H, Carpenter CB, et al. (2000) Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 6: 207?10. 24. Bohnhorst J? Bj gan MB, Thoen JE, Natvig JB, Thompson KM (2001) Bm1Bm5 classification of peripheral blood B cells reveals circulating germinal center founder cells in healthy individuals and distur
1
Vaccines. Recombinant poxvirus vaccines are worthy candidates given the wealth of experience using vaccinia for smallpox immunization programs in humans, and the development of recombinant techniques that enable insertion of substantial lengths of foreign DNA [1?]. More recently, attenuated strains of vaccinia have been developed (modified vaccinia Ankara; MVA) that are safer for use in young or i
1
Id onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration. J Virol 82: 538?45. 30. Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, et al. (2003) New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency viru